Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec 7;49(94):11007-22.
doi: 10.1039/c3cc44272a.

Bioorthogonal chemistry: strategies and recent developments

Affiliations
Review

Bioorthogonal chemistry: strategies and recent developments

Carlo P Ramil et al. Chem Commun (Camb). .

Erratum in

  • Chem Commun (Camb). 2014 Aug 28;50(67):9595

Abstract

The use of covalent chemistry to track biomolecules in their native environment-a focus of bioorthogonal chemistry-has received considerable interest recently among chemical biologists and organic chemists alike. To facilitate wider adoption of bioorthogonal chemistry in biomedical research, a central effort in the last few years has been focused on the optimization of a few known bioorthogonal reactions, particularly with respect to reaction kinetics improvement, novel genetic encoding systems, and fluorogenic reactions for bioimaging. During these optimizations, three strategies have emerged, including the use of ring strain for substrate activation in the cycloaddition reactions, the discovery of new ligands and privileged substrates for accelerated metal-catalysed reactions, and the design of substrates with pre-fluorophore structures for rapid "turn-on" fluorescence after selective bioorthogonal reactions. In addition, new bioorthogonal reactions based on either modified or completely unprecedented reactant pairs have been reported. Finally, increasing attention has been directed toward the development of mutually exclusive bioorthogonal reactions and their applications in multiple labeling of a biomolecule in cell culture. In this feature article, we wish to present the recent progress in bioorthogonal reactions through the selected examples that highlight the above-mentioned strategies. Considering increasing sophistication in bioorthogonal chemistry development, we strive to project several exciting opportunities where bioorthogonal chemistry can make a unique contribution to biology in the near future.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structure of ligands for biocompatible copper-catalysed azide-alkyne cycloaddition.
Figure 2
Figure 2
Evolution of strained alkyne reagents for strain-promoted azide-alkyne cycloaddition showing improved kinetics.
Figure 3
Figure 3
Genetically encoded amino acids for tetrazine ligation.
Scheme 1
Scheme 1
Proposed mechanism for the copper-catalysed azide-alkyne cycloaddition with two copper atoms.
Scheme 2
Scheme 2
Bioorthogonal labeling via strain-promoted azide-alkyne cycloaddition.
Scheme 3
Scheme 3
Cell surface labeling via tetrazine ligation using cyclopropene as a bioorthogonal reporter.
Scheme 4
Scheme 4
Photoinduced protein labeling via photolick chemistry.
Scheme 5
Scheme 5
Protein modification via strain-promoted alkyne-nitrone cycloaddition.
Scheme 6
Scheme 6
Palladium-catalysed bioorthogonal cross-coupling reactions for protein modification.
Scheme 7
Scheme 7
Newly developed bioorthogonal reactions.

References

    1. Johnson FH, Saiga Y. J. Cell. Physiol. 1962;59:223–239. - PubMed
    1. Tsien RY. Annu. Rev. Biochem. 1998;67:509–544. - PubMed
    1. Giepmans BNG, Adams SR, Ellisman MH, Tsien RY. Science. 2006;312:217–224. - PubMed
    1. Sletten EM, Bertozzi CR. Angew. Chem. Intl. Ed. 2009;48:6974–6998. - PMC - PubMed
    1. Laughlin ST, Bertozzi CR. Proceedings of the National Academy of Sciences of the United States of America. 2009;106:12–17. - PMC - PubMed

Publication types